Barker PE - Search Results

1

Measurement reproducibility in the early stages of biomarker development.

Liggett WS, Barker PE, Semmes OJ, Cazares LH. Liggett WS, et al. Among authors: barker pe. Dis Markers. 2004;20(6):295-307. doi: 10.1155/2004/726517. Dis Markers. 2004. PMID: 15665389 Free PMC article.

2

Nanotechnology: Emerging Developments and Early Detection of Cancer. A two-day workshop sponsored by the National Cancer Institute and the National Institute of Standards and Technology, August 30-31 2001, on the National Institute of Standards and Technology Campus, Gaithersburg, MD, USA.

Zullo SJ, Srivastava S, Looney JP, Barker PE. Zullo SJ, et al. Among authors: barker pe. Dis Markers. 2002;18(4):153-8. doi: 10.1155/2002/591527. Dis Markers. 2002. PMID: 12590168 Free PMC article. Review.

3

Mitochondrial DNA as a cancer biomarker.

Jakupciak JP, Wang W, Markowitz ME, Ally D, Coble M, Srivastava S, Maitra A, Barker PE, Sidransky D, O'Connell CD. Jakupciak JP, et al. Among authors: barker pe. J Mol Diagn. 2005 May;7(2):258-67. doi: 10.1016/S1525-1578(10)60553-3. J Mol Diagn. 2005. PMID: 15858150 Free PMC article.

4

Measurement of DNA biomarkers for the safety of tissue-engineered medical products, using artificial skin as a model.

Rodriguez H, O'Connell C, Barker PE, Atha DH, Jaruga P, Birincioglu M, Marino M, McAndrew P, Dizdaroglu M. Rodriguez H, et al. Among authors: barker pe. Tissue Eng. 2004 Sep-Oct;10(9-10):1332-45. doi: 10.1089/ten.2004.10.1332. Tissue Eng. 2004. PMID: 15588394

5

Analytical validation of telomerase activity for cancer early detection: TRAP/PCR-CE and hTERT mRNA quantification assay for high-throughput screening of tumor cells.

Jakupciak JP, Wang W, Barker PE, Srivastava S, Atha DH. Jakupciak JP, et al. Among authors: barker pe. J Mol Diagn. 2004 Aug;6(3):157-65. doi: 10.1016/S1525-1578(10)60506-5. J Mol Diagn. 2004. PMID: 15269291 Free PMC article.

6

Cancer biomarker validation: standards and process: roles for the National Institute of Standards and Technology (NIST).

Barker PE. Barker PE. Ann N Y Acad Sci. 2003 Mar;983:142-50. doi: 10.1111/j.1749-6632.2003.tb05969.x. Ann N Y Acad Sci. 2003. PMID: 12724219 Review.

7

Standards for plasma and serum proteomics in early cancer detection: a needs assessment report from the national institute of standards and technology--National Cancer Institute Standards, Methods, Assays, Reagents and Technologies Workshop, August 18-19, 2005.

Barker PE, Wagner PD, Stein SE, Bunk DM, Srivastava S, Omenn GS. Barker PE, et al. Clin Chem. 2006 Sep;52(9):1669-74. doi: 10.1373/clinchem.2006.067249. Epub 2006 Jul 13. Clin Chem. 2006. PMID: 16840585

8

Biomarker Validation for Aging: Lessons from mtDNA Heteroplasmy Analyses in Early Cancer Detection.

Barker PE, Murthy M. Barker PE, et al. Biomark Insights. 2009 Nov 27;4:165-79. doi: 10.4137/bmi.s2253. Biomark Insights. 2009. PMID: 20029650 Free PMC article.

9

Preparation and characterization of candidate reference materials for telomerase assays.

Jakupciak JP, Barker PE, Wang W, Srivastava S, Atha DH. Jakupciak JP, et al. Among authors: barker pe. Clin Chem. 2005 Aug;51(8):1443-50. doi: 10.1373/clinchem.2004.044727. Epub 2005 Jun 10. Clin Chem. 2005. PMID: 15951318

10

Quantitative infrared spectroscopy of formalin-fixed, paraffin-embedded tissue specimens: paraffin wax removal with organic solvents.

Meuse CW, Barker PE. Meuse CW, et al. Among authors: barker pe. Appl Immunohistochem Mol Morphol. 2009 Dec;17(6):547-52. doi: 10.1097/PAI.0b013e3181a9300e. Appl Immunohistochem Mol Morphol. 2009. PMID: 19786865

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page